Martin Wagner
- Oncology top 0.5%
- Epidemiology top 0.5%
- Surgery top 1%
- Hepatology top 0.5%
- Molecular Biology top 10%
- Co-authors
- Michael TraunerGernot ZollnerPeter FickertHanns–Ulrich MarschallAndrea FuchsbichlerHelmut DenkKurt ZatloukalDagmar Silbert
- Topics
- Drug Transport and Resistance Mechanisms (53 papers)Pediatric Hepatobiliary Diseases and Treatments (29 papers)Liver Disease Diagnosis and Treatment (25 papers)
- Cited by
- HepatologyOncologyPharmacology
- Partner nations
- AustriaUnited StatesSweden
In The Last Decade
Martin Wagner
79 papers receiving 6.1k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Oncology 3.3k
- Epidemiology 2.6k
- Surgery 2.2k
- Hepatology 1.8k
- Molecular Biology 1.2k
Countries citing papers authored by Martin Wagner
This map shows the geographic impact of Martin Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Wagner more than expected).
Fields of papers citing papers by Martin Wagner
This network shows the impact of papers produced by Martin Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Wagner. The network helps show where Martin Wagner may publish in the future.
Co-authorship network of co-authors of Martin Wagner
This figure shows the co-authorship network connecting the top 25 collaborators of Martin Wagner. A scholar is included among the top collaborators of Martin Wagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Wagner. Martin Wagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 59 | |
| 3 | 7 | |
| 4 | 60 | |
| 5 | 49 | |
| 6 | 19 | |
| 7 | 7 | |
| 8 | 30 | |
| 9 | 76 | |
| 10 | 1 | |
| 11 | 192 | |
| 12 | 26 | |
| 13 | 236 | |
| 14 | 138 | |
| 15 | 28 | |
| 16 | 97 | |
| 17 | 112 | |
| 18 | 237 | |
| 19 | 21 | |
| 20 | 5 |
About Martin Wagner
Martin Wagner is a scholar working on Hepatology, Oncology and Pharmacology, having authored 81 papers that have together received 6.2k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (53 papers), Pediatric Hepatobiliary Diseases and Treatments (29 papers) and Liver Disease Diagnosis and Treatment (25 papers). The work is most often cited by research in Hepatology (1.8k citations), Oncology (3.3k citations) and Pharmacology (990 citations). Martin Wagner has collaborated with scholars based in Austria, United States and Sweden. Frequent co-authors include Michael Trauner, Gernot Zollner, Peter Fickert, Hanns–Ulrich Marschall, Andrea Fuchsbichler, Helmut Denk, Kurt Zatloukal, Dagmar Silbert, David D. Moore and Katrin Panzitt. Their work appears in journals such as Nature, Journal of Clinical Investigation and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.